Research map: Commentary regarding “Electroacupuncture combined with fruquintinib and sintilimab in microsatellite-stable metastatic colorectal cancer: A phase II study”

Back to the article

Papers in this map

  1. A neuroanatomical basis for electroacupuncture to drive the vagal–adrenal axis · Shenbin Liu · 2021 · 831 citations · Cited by this paper
  2. Optimized L1CAM-CAR T cells enhance activity against moderate-antigen-density rhabdomyosarcoma models · 2026 · Related
  3. Tailoring traditional Chinese medicine in cancer therapy · Shuiquan Li · 2025 · 160 citations · Cited by this paper
  4. VG161 oncolytic virus remodels the tumor microenvironment by expanding CD3+ macrophages and enhancing antitumor immunity · 2026 · Related
  5. Acupuncture Point Specificity · Jingjing Xing · 2013 · 81 citations · Cited by this paper
  6. GSN liquid-liquid phase separation induces PANoptosis by inhibiting YAP-dependent glycolysis to alleviate the progression of clear cell renal cell carcinoma · 2026 · Related
  7. The quality of Cochrane systematic reviews of acupuncture: an overview · Zhaochen Ji · 2020 · 26 citations · Cited by this paper
  8. Mechano-activation of osteocytic connexin hemichannels prime microenvironment in suppressing breast cancer bone metastasis · 2026 · Related
  9. Exploring Acupuncture Actions in the Body and Brain · In‐Seon Lee · 2022 · 22 citations · Cited by this paper
  10. The m6A epitranscriptome in cancer therapy resistance: From cellular plasticity and metabolic rewiring to immune escape and therapeutic targeting · 2026 · Related
  11. Electroacupuncture combined with fruquintinib and sintilimab in microsatellite-stable metastatic colorectal cancer: A phase II study · Caiqi Liu · 2026 · 2 citations · Cited by this paper
  12. Elevated FN14 expression promotes proliferation, chemoresistance, and impairment of differentiation in rhabdomyosarcoma · 2026 · Related
  13. Targeting MDA-9/syntenin-1 (SDCBP) as a strategy to eliminate head and neck squamous cell carcinoma stem cells · 2026 · Related
  14. Antibody-drug conjugates against multidrug-resistant cancers: Biomarker-guided patient selection, payload engineering, linker chemistry, and bystander effects · 2026 · Related
  15. Immunotherapy-based combination remodels the immunosuppressive microenvironment and enhances efficacy in advanced SMARCA4-deficient non-small cell lung cancer · 2026 · Related
  16. Early-onset lung cancer: etiologic heterogeneity, genomic features, and age-informed clinical management · 2026 · Related

Source: OpenAlex (CC0)